“…Targeted nanoscaled chitosan (CS)‐based DDSs are the subject of interest as targeted carriers of therapeutics and diagnostics agents to cancer cells, which have improved systemic performance in cancer detection and therapy (Figure ; Chen et al, ; Park et al, ). The CS, as natural biopolymer, has excellent biocompatibility, biodegradability, great bioavailability, hydrophilicity, and low toxicity, and it has also practical application in different forms including nanomicelles, NPs, microspheres, hydrogels, biofilms, and tablets (Rege, Garmise, & Block, ; Rezvani, Mohammadnejad, Narmani, & Bidaki, ).…”